| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Vessel Anomalies | 53 | 2026 | 279 | 19.510 |
Why?
|
| Coronary Vessels | 36 | 2026 | 521 | 7.490 |
Why?
|
| Death, Sudden, Cardiac | 26 | 2025 | 268 | 5.920 |
Why?
|
| Fractional Flow Reserve, Myocardial | 8 | 2025 | 54 | 3.630 |
Why?
|
| Aorta | 24 | 2025 | 521 | 3.590 |
Why?
|
| Athletes | 13 | 2025 | 77 | 2.470 |
Why?
|
| Myocardial Ischemia | 7 | 2025 | 307 | 2.260 |
Why?
|
| Aorta, Thoracic | 11 | 2024 | 530 | 2.010 |
Why?
|
| Exercise | 8 | 2024 | 892 | 1.830 |
Why?
|
| Coronary Angiography | 16 | 2026 | 450 | 1.760 |
Why?
|
| Coronary Artery Disease | 9 | 2023 | 887 | 1.350 |
Why?
|
| Vascular Surgical Procedures | 5 | 2021 | 534 | 1.310 |
Why?
|
| Sports | 6 | 2025 | 68 | 1.250 |
Why?
|
| Computed Tomography Angiography | 12 | 2024 | 216 | 1.180 |
Why?
|
| Myocardial Perfusion Imaging | 5 | 2024 | 60 | 1.170 |
Why?
|
| Child | 48 | 2025 | 26341 | 1.150 |
Why?
|
| Exercise Test | 7 | 2024 | 239 | 1.060 |
Why?
|
| Hydrodynamics | 2 | 2025 | 29 | 1.030 |
Why?
|
| Models, Cardiovascular | 2 | 2025 | 165 | 0.970 |
Why?
|
| Risk Assessment | 14 | 2026 | 3711 | 0.960 |
Why?
|
| Myocardial Bridging | 2 | 2024 | 14 | 0.940 |
Why?
|
| Sports Medicine | 6 | 2025 | 32 | 0.930 |
Why?
|
| Humans | 93 | 2026 | 131163 | 0.930 |
Why?
|
| Adolescent | 30 | 2025 | 20987 | 0.880 |
Why?
|
| Heart Arrest | 5 | 2023 | 356 | 0.850 |
Why?
|
| Terminology as Topic | 1 | 2026 | 226 | 0.830 |
Why?
|
| Sinus of Valsalva | 2 | 2024 | 33 | 0.760 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2021 | 216 | 0.730 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 4066 | 0.710 |
Why?
|
| Triglycerides | 1 | 2024 | 602 | 0.710 |
Why?
|
| Cholesterol | 1 | 2024 | 539 | 0.700 |
Why?
|
| Chest Pain | 2 | 2019 | 133 | 0.690 |
Why?
|
| Male | 41 | 2025 | 64957 | 0.670 |
Why?
|
| Lipids | 1 | 2024 | 569 | 0.660 |
Why?
|
| Coronary Sinus | 1 | 2021 | 12 | 0.660 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2019 | 26 | 0.620 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2020 | 19 | 0.620 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2024 | 1168 | 0.610 |
Why?
|
| Myocarditis | 1 | 2021 | 122 | 0.610 |
Why?
|
| Cardiac Catheterization | 7 | 2024 | 630 | 0.600 |
Why?
|
| Electrocardiography | 9 | 2025 | 970 | 0.580 |
Why?
|
| Fibronectins | 11 | 1999 | 99 | 0.560 |
Why?
|
| Magnetic Resonance Imaging, Cine | 5 | 2021 | 176 | 0.550 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2023 | 161 | 0.550 |
Why?
|
| Hemodynamic Monitoring | 1 | 2018 | 17 | 0.550 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2023 | 2065 | 0.530 |
Why?
|
| Predictive Value of Tests | 6 | 2026 | 2304 | 0.520 |
Why?
|
| Parents | 1 | 2024 | 1128 | 0.490 |
Why?
|
| Needs Assessment | 1 | 2017 | 173 | 0.470 |
Why?
|
| Heart Transplantation | 9 | 2024 | 800 | 0.460 |
Why?
|
| Female | 33 | 2024 | 70963 | 0.450 |
Why?
|
| Prospective Studies | 10 | 2024 | 6459 | 0.450 |
Why?
|
| Quality of Life | 3 | 2021 | 2082 | 0.450 |
Why?
|
| Risk Factors | 13 | 2026 | 11074 | 0.430 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 305 | 0.430 |
Why?
|
| Hemodynamics | 3 | 2025 | 810 | 0.420 |
Why?
|
| Treatment Outcome | 12 | 2024 | 12936 | 0.410 |
Why?
|
| Family | 1 | 2017 | 589 | 0.400 |
Why?
|
| Cardiovascular Diseases | 6 | 2025 | 2121 | 0.400 |
Why?
|
| Mass Screening | 6 | 2018 | 822 | 0.400 |
Why?
|
| Disease Management | 1 | 2017 | 558 | 0.390 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2024 | 682 | 0.380 |
Why?
|
| Prognosis | 6 | 2026 | 4886 | 0.380 |
Why?
|
| Retrospective Studies | 16 | 2024 | 17753 | 0.370 |
Why?
|
| Interleukin-1 | 7 | 1996 | 130 | 0.360 |
Why?
|
| Decision Support Techniques | 3 | 2020 | 293 | 0.340 |
Why?
|
| Norwood Procedures | 2 | 2022 | 96 | 0.320 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 457 | 0.310 |
Why?
|
| Coronary Stenosis | 2 | 2021 | 78 | 0.300 |
Why?
|
| Consensus | 5 | 2026 | 512 | 0.300 |
Why?
|
| Lymphocytes | 3 | 1995 | 344 | 0.300 |
Why?
|
| Ischemia | 2 | 2023 | 359 | 0.300 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 567 | 0.300 |
Why?
|
| Clinical Decision-Making | 3 | 2020 | 314 | 0.280 |
Why?
|
| Vascular Malformations | 2 | 2021 | 103 | 0.280 |
Why?
|
| Angiography | 3 | 2023 | 179 | 0.280 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2022 | 261 | 0.280 |
Why?
|
| Pulmonary Artery | 3 | 2024 | 434 | 0.280 |
Why?
|
| Child, Preschool | 8 | 2024 | 15110 | 0.270 |
Why?
|
| Heart Defects, Congenital | 3 | 2024 | 1889 | 0.270 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 3061 | 0.260 |
Why?
|
| Incidence | 4 | 2018 | 3360 | 0.250 |
Why?
|
| Replantation | 3 | 2023 | 51 | 0.240 |
Why?
|
| Cardiology | 2 | 2025 | 514 | 0.240 |
Why?
|
| American Heart Association | 2 | 2025 | 343 | 0.230 |
Why?
|
| Receptors, Very Late Antigen | 2 | 1995 | 4 | 0.230 |
Why?
|
| International Cooperation | 1 | 2026 | 165 | 0.220 |
Why?
|
| Incidental Findings | 2 | 2024 | 122 | 0.220 |
Why?
|
| Direct-To-Consumer Screening and Testing | 1 | 2025 | 14 | 0.220 |
Why?
|
| Abnormalities, Multiple | 3 | 2024 | 963 | 0.220 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2025 | 51 | 0.220 |
Why?
|
| Calibration | 1 | 2025 | 92 | 0.220 |
Why?
|
| Computer Simulation | 2 | 2025 | 674 | 0.210 |
Why?
|
| Heart Diseases | 3 | 2018 | 499 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2026 | 283 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1459 | 0.210 |
Why?
|
| Endothelium, Vascular | 5 | 1995 | 468 | 0.210 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 5196 | 0.210 |
Why?
|
| Adult | 14 | 2024 | 31282 | 0.210 |
Why?
|
| Postoperative Complications | 4 | 2021 | 3147 | 0.200 |
Why?
|
| Secondary Prevention | 1 | 2025 | 217 | 0.200 |
Why?
|
| Long QT Syndrome | 1 | 2024 | 86 | 0.200 |
Why?
|
| Primary Prevention | 1 | 2025 | 183 | 0.200 |
Why?
|
| Young Adult | 10 | 2024 | 10103 | 0.190 |
Why?
|
| Cholesterol, HDL | 1 | 2024 | 383 | 0.190 |
Why?
|
| Mitral Valve | 1 | 2025 | 247 | 0.190 |
Why?
|
| Algorithms | 2 | 2020 | 1680 | 0.180 |
Why?
|
| Echocardiography | 4 | 2025 | 1125 | 0.180 |
Why?
|
| Coronary Disease | 4 | 1995 | 624 | 0.170 |
Why?
|
| United States | 8 | 2025 | 12072 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 1999 | 639 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3763 | 0.170 |
Why?
|
| Health Behavior | 1 | 2024 | 387 | 0.170 |
Why?
|
| Shock, Cardiogenic | 1 | 2023 | 176 | 0.170 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2024 | 229 | 0.170 |
Why?
|
| Coronary Thrombosis | 1 | 2021 | 33 | 0.160 |
Why?
|
| Fistula | 1 | 2021 | 50 | 0.160 |
Why?
|
| Infant, Newborn | 5 | 2024 | 8635 | 0.160 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 1996 | 223 | 0.150 |
Why?
|
| Heart Septal Defects | 1 | 2020 | 42 | 0.150 |
Why?
|
| Defibrillators | 1 | 2019 | 14 | 0.150 |
Why?
|
| Perfusion | 1 | 2021 | 209 | 0.150 |
Why?
|
| Heart Ventricles | 1 | 2024 | 749 | 0.150 |
Why?
|
| Arterio-Arterial Fistula | 2 | 2016 | 10 | 0.150 |
Why?
|
| Aortic Valve | 1 | 2022 | 455 | 0.150 |
Why?
|
| Infant | 5 | 2024 | 13352 | 0.140 |
Why?
|
| Students | 5 | 2016 | 250 | 0.140 |
Why?
|
| Data Warehousing | 1 | 2018 | 5 | 0.140 |
Why?
|
| Time Factors | 2 | 2020 | 6196 | 0.140 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 262 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2025 | 1106 | 0.140 |
Why?
|
| Cardiomegaly, Exercise-Induced | 1 | 2017 | 1 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 482 | 0.130 |
Why?
|
| Cell Adhesion Molecules | 2 | 1995 | 223 | 0.130 |
Why?
|
| Heart | 2 | 2021 | 650 | 0.130 |
Why?
|
| Preventive Health Services | 1 | 2017 | 59 | 0.130 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 999 | 0.120 |
Why?
|
| Turner Syndrome | 1 | 2016 | 44 | 0.120 |
Why?
|
| Congresses as Topic | 1 | 2017 | 184 | 0.120 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 515 | 0.120 |
Why?
|
| Age Factors | 2 | 2020 | 2825 | 0.120 |
Why?
|
| Health Resources | 1 | 2017 | 131 | 0.120 |
Why?
|
| Cell Movement | 4 | 1995 | 876 | 0.120 |
Why?
|
| Receptors, Fibronectin | 1 | 1995 | 7 | 0.120 |
Why?
|
| Ultrasonography, Interventional | 2 | 2017 | 205 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2020 | 562 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1995 | 73 | 0.110 |
Why?
|
| Graft Rejection | 3 | 1995 | 552 | 0.110 |
Why?
|
| Patient Selection | 1 | 2019 | 729 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 1995 | 116 | 0.110 |
Why?
|
| Peptides | 2 | 1995 | 708 | 0.110 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 143 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2020 | 1240 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2017 | 396 | 0.110 |
Why?
|
| Cyclosporine | 1 | 1995 | 132 | 0.110 |
Why?
|
| Physical Examination | 3 | 2016 | 171 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2017 | 730 | 0.100 |
Why?
|
| Motor Activity | 1 | 2016 | 489 | 0.090 |
Why?
|
| Life Style | 1 | 2016 | 456 | 0.090 |
Why?
|
| Swine | 6 | 1996 | 1186 | 0.090 |
Why?
|
| Global Health | 1 | 2017 | 626 | 0.090 |
Why?
|
| Survival Rate | 1 | 2017 | 2114 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2014 | 943 | 0.080 |
Why?
|
| Rabbits | 4 | 1995 | 575 | 0.070 |
Why?
|
| Palliative Care | 2 | 2022 | 443 | 0.060 |
Why?
|
| Reoperation | 2 | 2021 | 818 | 0.060 |
Why?
|
| Texas | 3 | 2020 | 3686 | 0.060 |
Why?
|
| Transplantation, Homologous | 4 | 1995 | 670 | 0.060 |
Why?
|
| Universities | 2 | 2016 | 125 | 0.060 |
Why?
|
| Advisory Committees | 2 | 2016 | 150 | 0.060 |
Why?
|
| Reference Values | 2 | 2018 | 676 | 0.060 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 1995 | 72 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1995 | 125 | 0.050 |
Why?
|
| Review Literature as Topic | 1 | 2025 | 55 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 1995 | 1591 | 0.050 |
Why?
|
| Ductus Arteriosus | 1 | 2024 | 59 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2024 | 161 | 0.050 |
Why?
|
| Aneurysm, Infected | 1 | 2002 | 23 | 0.050 |
Why?
|
| Heart Failure | 1 | 2016 | 2332 | 0.050 |
Why?
|
| Financing, Government | 1 | 2012 | 33 | 0.050 |
Why?
|
| State Government | 1 | 2012 | 33 | 0.050 |
Why?
|
| Pregnancy | 1 | 2014 | 7512 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 2395 | 0.040 |
Why?
|
| Dobutamine | 1 | 2021 | 48 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 3464 | 0.040 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2002 | 150 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2024 | 506 | 0.040 |
Why?
|
| Printing, Three-Dimensional | 1 | 2021 | 88 | 0.040 |
Why?
|
| Animals | 9 | 1996 | 33912 | 0.040 |
Why?
|
| Tibial Arteries | 1 | 1999 | 8 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 1295 | 0.040 |
Why?
|
| Diabetic Angiopathies | 1 | 1999 | 66 | 0.040 |
Why?
|
| Tunica Intima | 2 | 1995 | 61 | 0.030 |
Why?
|
| Femoral Artery | 1 | 1999 | 134 | 0.030 |
Why?
|
| North America | 1 | 2019 | 255 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 371 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 149 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1995 | 71 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 587 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2012 | 1445 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2021 | 824 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2002 | 571 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 2 | 1995 | 15 | 0.030 |
Why?
|
| Glycosaminoglycans | 2 | 1996 | 42 | 0.030 |
Why?
|
| Washington | 1 | 2017 | 34 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 1996 | 420 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1996 | 25 | 0.030 |
Why?
|
| Coronary Care Units | 1 | 2016 | 34 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2016 | 113 | 0.030 |
Why?
|
| Emergency Treatment | 1 | 2016 | 78 | 0.030 |
Why?
|
| Diet, Atherogenic | 1 | 1995 | 14 | 0.030 |
Why?
|
| Acute Disease | 2 | 2016 | 1153 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 195 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1995 | 140 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 1995 | 112 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2016 | 153 | 0.030 |
Why?
|
| Culture Media | 1 | 1995 | 171 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1995 | 101 | 0.030 |
Why?
|
| Diuretics | 1 | 2016 | 159 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 133 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 351 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1995 | 358 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1995 | 308 | 0.030 |
Why?
|
| Longevity | 1 | 2016 | 178 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 808 | 0.030 |
Why?
|
| Arteries | 1 | 1995 | 208 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 5063 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 3436 | 0.030 |
Why?
|
| Antibodies | 1 | 1995 | 322 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1995 | 288 | 0.020 |
Why?
|
| Health Status | 1 | 2016 | 378 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1993 | 234 | 0.020 |
Why?
|
| Myocardium | 2 | 1995 | 852 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 1996 | 2885 | 0.020 |
Why?
|
| T-Lymphocytes | 3 | 1999 | 1722 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1995 | 765 | 0.020 |
Why?
|
| Middle Aged | 4 | 2024 | 28601 | 0.020 |
Why?
|
| Binding Sites | 1 | 1995 | 1133 | 0.020 |
Why?
|
| Pulmonary Valve | 1 | 1993 | 83 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2016 | 471 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1993 | 132 | 0.020 |
Why?
|
| Curriculum | 1 | 2017 | 798 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2016 | 564 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3829 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1995 | 687 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1993 | 633 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 689 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 1993 | 190 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2017 | 722 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2016 | 1246 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1345 | 0.020 |
Why?
|
| Calcium | 1 | 2016 | 1010 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2017 | 1050 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2016 | 561 | 0.020 |
Why?
|
| Cytokines | 1 | 1995 | 1339 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1993 | 2550 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 1995 | 4697 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 1999 | 235 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 21025 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1999 | 109 | 0.010 |
Why?
|
| Acetylgalactosamine | 1 | 1996 | 12 | 0.010 |
Why?
|
| Elastin | 1 | 1996 | 32 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1995 | 17 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1995 | 73 | 0.010 |
Why?
|
| Atherectomy | 1 | 1995 | 11 | 0.010 |
Why?
|
| Hyaluronan Receptors | 1 | 1995 | 64 | 0.010 |
Why?
|
| Macrophages | 1 | 1999 | 667 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 1994 | 49 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1995 | 161 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1996 | 450 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1996 | 825 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1993 | 20 | 0.010 |
Why?
|
| Aortography | 1 | 1993 | 155 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1993 | 305 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1993 | 187 | 0.010 |
Why?
|
| Biopsy | 1 | 1995 | 1239 | 0.010 |
Why?
|
| Recurrence | 1 | 1995 | 1489 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1995 | 993 | 0.000 |
Why?
|
| Biomarkers | 1 | 1999 | 3385 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1993 | 1882 | 0.000 |
Why?
|